Agendia, Inc., a commercial stage company focused on precision oncology for breast cancer, today announced a multi-year partnership with Illumina, Inc. (NASDAQ: ILMN), to...
Vestibular First LLC announced it has added a new infection control measure to its FDA-cleared, low-cost tool for diagnosing dizziness, imbalance and vertigo, which...
Regnum Corp., and SevenScore Pharmaceuticals, LLC ("SevenScore"), announced the assignment of the Commercialization and License Agreement ("CLA") and a related Supply Agreement to commercialize...
Medtronic plc , a global leader in healthcare technology, announced it has received approval from Japan's Ministry of Health, Labor and Welfare for the...
COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles (CNPs) to treat immune disorders, today announced the U.S. Food and Drug Administration (FDA) granted...
